Enhancing Poly-ε-Caprolactone Implant Performance: Synergistic Surface Modifications With Osteon-Like Microstructure, Cold Atmospheric Plasma, and Extracellular Matrix Coating

增强聚己内酯植入物性能:骨样微结构、冷大气等离子体和细胞外基质涂层的协同表面改性

阅读:1

Abstract

Surface modifications of polycaprolactone (PCL) implants influence osseointegration by altering cell adhesion, proliferation, and differentiation. Osteon-like microtopography has been shown to enhance these parameters compared to untreated PCL. Additional treatments, such as cold atmospheric plasma (CAP) and extracellular matrix (ECM) coatings, may further improve bioactivity. This study evaluates and compares the osteogenic potential of osteon-like microtopography, CAP treatment on non-microstructured PCL, ECM coating on non-microstructured PCL, and their combination. Modified PCL samples were analyzed for cell adhesion, proliferation, and differentiation using primary human mesenchymal stem cells. Compared to osteon-like microtopography, CAP-treated and ECM-coated surfaces the combination of all three increased cell adhesion by nearly two-fold. Cell proliferation followed a similar trend, with the combination treatment showing the greatest enhancement by day 10. Alkaline phosphatase activity peaked with osteon-like microtopography, while mineralization was maximized with the combination treatment. In summary, the integration of osteon-like microtopography with CAP treatment and ECM coating synergistically improves cell adhesion, proliferation, and differentiation, offering a promising strategy for optimizing PCL implants to improve osseointegration.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。